Free Trial
TSE:PLI

ProMetic Life Sciences (PLI) Stock Price, News & Analysis

ProMetic Life Sciences logo

About ProMetic Life Sciences Stock (TSE:PLI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
921 shs
Average Volume
8,002 shs
Market Capitalization
C$317.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.

Receive PLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMetic Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

PLI Stock News Headlines

TMC Life Sciences Bhd (TMCN)
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.
TSX:CVE (CENOVUS ENERGY INC.)
See More Headlines

PLI Stock Analysis - Frequently Asked Questions

Shares of PLI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProMetic Life Sciences investors own include Nemaska Lithium (NMX), Crescent Point Energy (CPG), ProMetic Life Sciences (PFSCF), Bombardier, Inc. Class B (BBD.B), Sierra Wireless (SWIR), Baytex Energy (BTE) and Dollarama (DOL).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:PLI
CIK
N/A
Fax
N/A
Employees
487
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$39.91 million
Price / Cash Flow
3.94
Book Value
C$6.07 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$317.06 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (TSE:PLI) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners